Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

Authors :: Büyükkaramikli, NC
de Groot, Saskia
Fayter, D
Wolff, R
Armstrong, N
Stirk, L
Worthy, G
Albuquerque de Almeida, Fernando
Kleijnen, J
Al, Maiwenn
Büyükkaramikli, NC
de Groot, Saskia
Fayter, D
Wolff, R
Armstrong, N
Stirk, L
Worthy, G
Albuquerque de Almeida, Fernando
Kleijnen, J
Al, Maiwenn
Source :: Büyükkaramikli , NC , de Groot , S , Fayter , D , Wolff , R , Armstrong , N , Stirk , L , Worthy , G , Albuquerque de Almeida , F , Kleijnen , J & Al , M 2017 , ' Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal ' , Pharmacoeconomics (Print) .
Publication Year :: 2017

Database :: OAIster
Journal :: Büyükkaramikli , NC , de Groot , S , Fayter , D , Wolff , R , Armstrong , N , Stirk , L , Worthy , G , Albuquerque de Almeida , F , Kleijnen , J & Al , M 2017 , ' Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal ' , Pharmacoeconomics (Print) .
Notes :: application/pdf, English
Publication Type :: Electronic Resource
Accession number :: edsoai.on1313621962
Document Type :: Electronic Resource

Tools